SAFETY REGULATORY PACKAGE

SAFETY REGULATORY PACKAGE Porsolt’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your GLP Safety Pharmacology experiments. Porsolt offers safety studies in both…

Continue Reading SAFETY REGULATORY PACKAGE

CENTRAL NERVOUS SYSTEM

CENTRAL NERVOUS SYSTEM Porsolt offers models in all areas of psychopharmacology, epilepsy, sleep-wake, and neurodegenerative disorders. We are uniquely placed to offer a full range of CNS efficacy and safety…

Continue Reading CENTRAL NERVOUS SYSTEM

OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor.

OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor. PORSOLT_OBE022-an-Oral-and-Selective-Prostaglandin-F2945-Receptor-Antagonist-as-an-Effective-and-Safe-Modality-for-the-Treatment-of-Preterm-Labor.Download   keywords : Drug Discovery, Translational Medicine, Drug…

Continue Reading OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor.

CRF1 receptor-deficiency increases cocaine reward

Stimulant drugs produce reward but also activate stress-responsive systems. The corticotropin-releasing factor (CRF) and the related hypothalamus-pituitary-adrenal (HPA) axis stress-responsive systems are activated by stimulant drugs. PORSOLT_CRF1-receptor-deficiency-increases-cocaine-reward.Download   Keywords: Cocaine; Corticotropin-releasing…

Continue Reading CRF1 receptor-deficiency increases cocaine reward